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proliferation ( > 47 000 cpm) in MLN from both suckling and weaned pigs after TGEV challenge. Substantial BLN proliferative responses ( > 80 000 cpm) correlated with failure to detect TGEV in nasal secretions from these pigs. Virus-specific lymphocyte proliferation in spleens was delayed in onset and of lower magnitude than that observed in MLN and BLN. Virulent TGEV exposure resulted in increased percentages of T cell subsets, especially in the lamina propria and MLN, mucosaassociated lymphoid tissues in proximity to the primary replication site of TGEV in the small intestine. Our results confirm that PRCV infection primes anti-viral immune responses and, thus, contributes to partial immunity against virulent TGEV challenge.
Introduction
Transmissible gastroenteritis virus (TGEV) and porcine respiratory coronavirus (PRCV), two antigenically related porcine coronaviruses with distinct intestinal and respiratory tissue tropisms, present a unique model for the study of immunologic interactions among mucosa-associated lymphoid tissues. TGEV infects and destroys villous enterocytes of the small intestine leading to vomiting, severe malabsorptive diarrhea, dehydration, and mortality approaching 100% in newborn susceptible pigs (Saif and Wesley, 1992) . Because effective vaccines and therapy are unavailable, the disease continues to negatively impact the swine industry. Infection of pigs with virulent TGEV elicits protective active immunity subsequent to enteric replication of the virus, stimulation of inductive sites in gut-associated lymphoid tissue (GALT), and production of virus-specific cell-mediated immunity, antibody-secreting cells ( ASC), and intestinal secretory IgA (Saif and Wesley, 1992; VanCott et al., 1993; Brim et al., 1994) . Protective lactogenic immunity conferred to pigs suckling sows that were immunized via natural exposure or oral inoculation with virulent TGEV is theorized to result from the migration of TGEV-specific IgA-committed B cells from GALT to the mammary glands where they mature into IgA-ASC and produce secretory IgA to TGEV in milk (Saif and Wesley, 1992) . TGEV infects the respiratory tract (Kemeny et al., 1975; Furuuchi et al., 1979; O'Toole et al., 1989) and stimulates virus-specific cellular and ASC immune responses in bronchial lymph nodes (BLN) (VanCott et al., 1993; Brim et al., 1994) ; however, the contribution of respiratory lymphoid tissue to protective immunity against TGEV is unclear.
PRCV was first identified in Europe in 1984 (Brown and Cartwright, 1986; Pensaert et al., 1986) and later in the USA Wesley et al., 1990) as the cause of mild respiratory disease or subclinical infections without enteritis in swine. Conventional serologic tests are unable to distinguish between PRCV and TGEV, although antigenic differentiation is possible with specific monoclonal antibodies (mAbs) in a serum blocking ELISA (Callebaut et al., 1988; Garwes et al., 1988; Van Nieuwstadt and Boonstra, 1992; Simkins et al., 1992) . PRCV replicates extensively in the respiratory tract, but intestinal PRCV replication is timited to a few villous subepithelial cells (Pensaert et al., 1986; Cox et al., 1990) . The mechanisms by which PRCV exposure induces a variable degree of active (Van Nieuwstadt et al., 1989; Wesley and Woods, 1992; Cox et al., 1993) and passive immunity (Bernard et al., 1989; Paton and Brown, 1990; De Diego et al., 1992) to TGEV infection are unclear. A bronchus-associated lymphoid tissue (BALT) -mammary immunologic link has been proposed to account for the appearance of TGEV-neutralizing secretory IgA in milk from PRCV-exposed sows (Callebaut et al., 1990) . Our recent studies with PRCV-inoculated pigs demonstrated vigorous virus-specific cell-mediated and ASC, primarily IgG, immune responses in BLN, but little stimulation of mesenteric lymph nodes (MLN) (VanCott et al., 1993; Brim et al., 1994) .
Clarification of cellular immune responses to TGEV and PRCV is essential for the control of these infections in pigs. Cell-mediated immunity may play a direct role in recovery from and protection against reinfection, and the terminal differentiation of IgA-committed B cells into IgA-ASC requires virus-specific T cell help (Mestecky and McGhee, 1987) . This article presents data that assesses the contribution of cell-mediated immunity to the protection conferred by primary TGEV or PRCV exposure of pigs against virulent TGEV infection. Changes in lymphocyte proliferative responses and in the distribution of mononuclear cell subsets after virus exposure were evaluated in MLN (draining lymph nodes for GALT), in BLN (draining lymph nodes for BALT and the lower respiratory tract), in the intestinal lamina propria (an effector site in GALT), and in spleens (systemic lymphoid organs).
Materials and methods

Viruses
The virulent Miller strain (MX) of TGEV (Bohl and Kumagai, 1965) , passaged in gnotobiotic pigs, and the PRCV strain ISU-1 ) passaged in swine testicle cells, were titered by plaque assays in swine testicle cells before they were inoculated into pigs. The low cell culture-passaged Miller strain (M6) of TGEV (Welch et al., 1988) was processed for use as viral antigen in lymphocyte proliferation assays, as previously described .
Experimental design
Eleven-day-old suckling pigs from crossbred sows that were seronegative for TGEVneutralizing antibodies were inoculated oronasally with virulent TGEV M5C ( 17 pigs from three litters, 5 X lo5 plaque-forming units (PFU) per pig) or PRCV ( 16 pigs from two litters, 2 X IO* PFU per pig). One-fifth of the total inoculum dose was administered via the intranasal route. Twenty-three age-matched uninoculated pigs from three litters served as controls. Each litter was housed in a separate isolation room during the experiments; each pig in these eight litters remained with its sow until euthanasia. On Postinoculation Day (PID) 24, 35day-old pigs from all three groups (TGEV, PRCV, and control) were given an oronasal challenge dose of virulent TGEV ( 1.3 X 10' PFU per pig). The rationale for the virus doses given to these pigs was detailed elsewhere . Animals were observed for clinical signs of gastroenteritis and respiratory infection, i.e. vomiting, diarrhea, nasal discharge, coughing, and dyspnea. Nasal and rectal swab specimens were collected from each pig before virus inoculation and challenge, then daily for 8 PID and 8 postchallenge days (PCD). Blood samples were drawn from selected pigs at the time of inoculation and challenge, on various PID and PCD, and from all pigs following euthanasia. Pigs were euthanized on PCD 0 (PID 24), 2, 4, 8, and 12. MLN, BLN, spleens, and segments of the small intestine were harvested for cell preparations that were tested in lymphocyte proliferation assays and flow cytometric analysis (FCM) . Tissues from eight TGEV-seronegative, unexposed suckling pigs from the same herd were also available for FCM. An additional ten pigs from one litter were inoculated with PRCV as above, then weaned at 3 weeks of age (PID 10). One litter of six age-matched weaned pigs served as controls. Both litters of weaned pigs were challenged with TGEV when 35 days old (PID 24); pigs were euthanized on PCD 0,4, and 12.
Virus neutralization test, cell culture immunojhorescence (CCIF), and immune electron microscopy (IEM)
Neutralizing antibody titers to TGEV and PRCV in serum samples were determined by a plaque reduction test (Bohl et al., 1972) . Virus was detected in rectal and nasal swab samples by a CCIF test with hyperimmune porcine anti-TGEV (cross-reactive with PRCV) immunoglobulin conjugated to fluorescein isothiocyanate (FITC; Welch et al., 1988; VanCott et al., 1993) . Titers were expressed as the number of fluorescing foci per milliliter of swab supernatant fluid. In addition, rectal swab specimens from PCD 2 and 3 were examined for TGEV particles by IEM (Saif et al., 1977) .
Flow cytometric analysis
Mononuclear cells were isolated from MLN, BLN, spleens, and the lamina propria of the small intestines and resuspended in complete culture medium, as described previously (VanCott et al., 1993 . Cell viability assessed by trypan blue exclusion was > 90% for cells from each tissue. Aliquots of mononuclear cells were stored frozen up to 1 year in liquid nitrogen. The recovery of frozen cells upon thawing was 5060% for cells from MLN, BLN, and spleens, and 20-25% for ileal and duodenal cells. Cells were incubated for 30 min at 4°C with the following mAbs specific for swine leukocyte surface antigens: PT85a (anti-Class I, monomorphic), MSA3 (anti-Class II, swine lymphocyte antigen (SLA) -DR), MSA4 (anti-CD2), 74-12-4 (anti-CD4), 76-2-11 (anti-CD8), 74-22-15 (anti-SWC3, macrophage/granulocyte) , 23 1.3B2 (anti-interleukin-2 receptor (IL-2R) ), 5C9 + IA1 1 (anti-IgM), 3Dll + 3H5 (anti-IgA), and 3H2 + 3H7 (anti-IgG) (Paul et al., 1989; Bailey et al., 1992; Lunney, 1993) . The mAbs were undiluted hybridoma culture supernatants except for the anti-Ig mAbs which were ascitic fluid diluted 1:lOO in Earl's balanced salt solution supplemented with 1% bovine serum albumin and 5% fetal bovine serum. Following two washes, cells were stained for 30 min at 4°C with a FITC-conjugated anti-mouse Ig reagent (goat anti-mouse IgG F( ab') 2; Kirkegaard&Perry Laboratories, Gaithersburg, MD). An EPICS Profile-II (Coulter, Hialeah, FL) was used to perform FCM of 10 000 immunofluorescing cells (Lunney et al., 1986) .
Lymphocyte proliferation
The lymphocyte proliferation assays were performed as described previously . Briefly, fresh mononuclear cells were plated at 4 X 16 cells per well in 96 well culture plates. Cell cultures were stimulated in triplicate with inactivated TGEV M6 viral antigen (5-20 pl), uninfected cell culture fluid (negative control), the T cell mitogen phytohemagglutinin (PHA) (positive control) (M form; GIBCO Laboratories, Grand Island, NY), or medium alone (background control). Mononuclear cells from the lamina propria were also stimulated with 1 pg per well of a second T cell mitogen, concanavalin A (Con A; Sigma Chemicals, St. Louis, MO). Doses of viral antigen, PHA, and Con A were optimized for the cell culture conditions specified. Cell cultures were incubated for 96 h (MLN, BLN, spleens) or 72 h (lamina propria) at 37°C in 5% COZ, then pulsed with 1 &i ["HI methylthymidine per well for an additional 18 h.
[ 3H]Thymidine incorporation was determined for each tissue sample and expressed as the mean cpm of [ 3H] thymidine incorporation for cells stimulated by TGEV antigen minus the mean cpm for cells stimulated by cell culture fluid (negative control), or as the mean cpm of PHA-and Con A-stimulated cultures minus the mean cpm of the background control which ranged from 500 to 9000 cpm. These corrected values for each pig's samples were then used to calculate group means + standard error of the mean (SEM) .
Statistical analysis
Statistical differences in proliferative responses among inoculum groups were determined by one-way analysis of variance on rank-transformed data. Fisher's least significant difference test was used to identify specific differences. A probability level of P<O.O5 was considered statistically significant. Proliferative responses below 40 000 cpm were defined as low, 40 000 to 80 000 cpm as moderate, and above 80 000 cpm as high.
Results
Clinical signs, virus shedding, and virus-neutralizing antibodies of suckling pigs
After primary inoculation with virulent TGEV M5C, 1 l-day-old pigs exhibited signs of severe gastroenteritis, i.e. vomiting and diarrhea, associated with the disease and shed virus in feces for 7 PID with a peak mean virus titer of 1.3 X lo4 focus-forming units per ml at PID 1 ( Fig. 1 (A) ). Intestinal virus replication was further confirmed by positive rectal swab samples from 76% of the pigs, Respiratory virus shedding after TGEV exposure was not as prevalent because only 24% of the pigs were positive for virus in nasal swab samples and the peak mean virus titer was IOOO-fold less than that in the feces (Fig. 1 (B) ). All three sows that werecontact-exposed to virulentTGEVfollowing inoculation oftheir piglets showed signs of anorexia but not agalactia from PID 3 to 5. Although clinical signs of disease were not observed in any PRCV-inoculated pigs, all of these pigs sustained respiratory infections as evidenced by virus shedding in nasal secretions; the peak mean virus titer was 2.3 X IO5 focus-forming units per ml at PID 1 ( Fig. 1 (B) ) Virus was not detected in feces from pigs given PRCV.
Pigs were challenged with virulent TGEV ( 1.3 X 10' PFU per pig) at 35 days of age to determine the degree of protective immunity afforded by primary PRCV exposure. Fortytwo percent of PRCV-inoculated pigs developed diarrhea after TGEV challenge; one of 16 pigs and ten of 12 pigs shed virus in feces when the samples were tested by CCIF and IEM, Pigs were inoculated with TGEV ( n ), PRCV (0). or no virus ( A ). and samples were collected daily through PID 8. At PID 24 (PCD 0), pigs from all three primary inoculum groups (TGEV. PRCV, and no virus) were challenged with TGEV; samples were collected daily through PCD 8 (PID 32) Data are presented as the mean fluorescing focus-forming unit per ml of swab supematant fluid of 16-23 samples ( *SEM) after primary inoculation and of 6-21 samples ( iSEM) after challenge. Data from samples without virus overlap and are indistinguishable from the baseline. SEM smaller than the symbols are not shown.
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Immunology und Immunopathology 48 (1995) 35-54 41 respectively. However, all pigs were completely protected against nasal virus shedding ( Fig. 1) . One PRCV-exposed pig euthanized at PCD 2 had villous atrophy in the jejunum and ileum, but intestinal lesions were not found in any pigs that were reinoculated with TGEV (R. Moxley, personal communication, 1992) . After receiving a 260-fold higher dose (challenge dose) of virulent TGEV than the primary dose given to 1 l-day-old pigs, 35day-old control pigs had diarrhea without vomiting; they exhibited virus shedding in feces for a shorter duration (4 days) and with a ten-fold lower peak mean virus titer than that observed in the younger pigs ( Fig. 1 (A) ). However, about half of the 35day-old TGEV-challenged control pigs shed virus in nasal secretions with a peak mean virus titer that was 50-fold higher than that in the younger pigs after primary TGEV exposure ( Fig.  1 (B) ) All primary TGEV-inoculated pigs were protected against both diarrhea and virus shedding from the intestinal and respiratory tracts when challenged with virulent TGEV (Fig. 1) .
The results for IEM of rectal swab samples and virus-neutralizing serum antibodies from these pigs were reported elsewhere . Briefly, when rectal swab supernatants from a portion of the challenged pigs were examined at PCD 2 and 3 for virus particles by IEM, ten of 12 PRCV-inoculated pigs, one of five TGEV-inoculated pigs, and seven of nine control pigs were positive for TGEV. All virus-inoculated pigs seroconverted and produced neutralizing antibodies to TGEV, and both the TGEV and PRCV groups had similar antibody titers at PID 24 before challenge. After TGEV challenge, serum antibody titers increased nearly lOO-fold in the PRCV group compared with less than a two-fold increase in the TGEV group. The control pigs challenged with TGEV seroconverted by PCD 8.
Flow cytometric analysis of immunostained cells from suckling pigs
At the time of tissue harvest, single cell suspensions preparations from each tissue were frozen; after thawing, cell subsets from TGEV-challenged pigs were compared with normal age-matched, unexposed pigs using mAbs immunostaining in FCM analysis. Details of the B cell subsets from these pigs were presented separately . The phenotypic characterization of mononuclear cells from unexposed 1 l-to 51-day-old pigs by FCM (Fig. 2) revealed that CD2+ T cells were least numerous in the ileal lamina propria ( 1 l-29%) and that the small intestine lamina propria yielded the lowest percentages of both CD4+ ( <21%) and CDS+ ( <8%) T cells (Figs. 2(B) and 2(C)). Percentages of CD2' (35-58%) and CD4' (2241%) cells in MLN, BLN, and spleens were similar (Figs. 2(A), 2(D) and 2(E) ). Overall, no association between the age of the pigs ( 1 l-5 1 days) and variation in percentages of cell subsets was noted.
After TGEV challenge, the percentages of CD2+ and CD4+ T cells in all five tissues generally increased over those found in age-matched unexposed pigs (Figs. 3(A) and 3(B) ), but the changes in control pigs after primary TGEV inoculation were most striking in MLN and the lamina propria (duodenum, ileum), lymphoid tissues adjacent to enterocytes of the small intestine, the major replication site of TGEV. CDS+ T cells followed the trends seen with CD2 + and CD4 + cells after virus exposure ( Fig. 3 (C) ) . The effect of time after virus exposure on T cell populations was assessed. These analyses revealed that MLN CD4+ T cells apparently increased after primary TGEV inoculation of 35-day-old control pigs; no such trends were observed in CD4+ cells from BLN (data not shown).
In spleen cells from TGEV-and PRCV-primed pigs, the sum of the CD4+ and CD8+ cells (73% and 64%, respectively) exceeded the percentage of the CD2+ cells (56% and 58%, respectively), implying that a portion of the T cell population was CD4+CD8+ (double positive) T cells (Figs. 3(A)-3(C)).
The presence of CD2+CD4_CD8-cells in the duodenal and ileal lamina propria T cell populations was suggested by the fact that the sum of the CD4+ and CD8+ cells was less than the percentage of CD2+ cells from unexposed pigs and from pigs in all three TGEV-challenged groups. Percentages of macrophages ranged from < 10% in MLN and BLN to 24% in the spleen and duodenum (Fig. 4(A) ). After TGEV challenge, percentages of sIg + B cells generally decreased in all tissues except the duodenum (Fig. 4(B) ). SLA Class I antigens were expressed on > 86% of cells in all tissues and no apparent shift in intensity of SLA Class I or Class II antigen expression in response to viral exposure was evident (Fig 4(C) ; data not shown). Changes in percentages of cells expressing SLA Class II paralleled changes in B cell percentages. Low-level expression of IL-2R was not affected by virus exposure (Fig.   4(D) ).
Virus-speci$c lymphocyte proliferative responses of suckling pigs
Overall, mononuclear cells purified from the mucosa-associated lymph nodes, MLN and BLN, gave vigorous virus-specific proliferative responses that were strongly associated with virus replication in the intestinal and respiratory tracts. Before challenge at PID 24 (PCD O), MLN cells from TGEV-inoculated pigs gave high ( > 96 000 cpm) virus-specific proliferative responses that were significantly higher (P = 0.02) than MLN responses from the PRCV and control groups, generally persisted after TGEV challenge, and correlated with protection against diarrhea and rectal virus shedding ( Fig. 5 (A) ) . MLN responses were very low ( < 10 000 cpm) in the PRCV group before challenge. TGEV challenge of PRCVexposed pigs induced a transient, moderate MLN virus-specific proliferation that peaked on PCD 4. Cells from MLN collected from control pigs challenged with TGEV showed an T.A. Brim et al. /Veterinary Immunology and Immunopathology 48 (1995) expected primary immune response in lymphocyte proliferation that by PCD 12 exceeded 100 000 cpm and attained the magnitude of proliferation exhibited by MLN cells from TGEV-reinoculated pigs. At PCD 8 and 12, proliferative responses in MLN cells from PRCV-inoculated pigs were lower than those in MLN cells from both primary and secondary TGEV-exposed pigs.
The magnitude of virus-specific proliferation assayed in this study was highest ( < 120 000 cpm) in BLN cells from TGEV and PRCV groups before challenge at PID 24 ( Fig. 5(B) ). BLN proliferative responses of PRCV-inoculated pigs generally remained high after TGEV challenge and correlated with protection against nasal virus shedding. In contrast, BLN cells from TGEV-reinoculated pigs showed a significant decrease in proliferation at PCD 4 and 8 that returned to a high level on PCD 12 (P < 0.04); these pigs were also protected against virus shedding in nasal secretions after challenge. BLN cells from control pigs challenged with TGEV gave a primary virus-specific immune response that was significant by PCD 2 and continued to increase to a high level approaching 100 000 cpm by PCD 12 (P = 0.03).
Spleen cells from TGEV and PRCV groups before challenge at PID 24 gave similar moderate proliferative responses that remained fairly constant after TGEV challenge ( Fig.  5(C) ). The induction at PCD 8 of a primary TGEV-specific proliferative response in spleen cells from control pigs challenged with TGEV lagged behind the onset of primary responses at PCD 2 that were demonstrated in MLN and BLN cells from these same control pigs. At PCD 16 and 20, cells from MLN, BLN, and spleens of five control pigs continued to give proliferative responses consistent with the primary immune response that was observed through PCD 12 (data not shown). Trends in MLN, BLN, and spleen responses were similar when the data were also calculated as a percentage of the mitogen proliferation for each sample (data not shown). Virus-specific lymphocyte proliferation was never detected in any of the lamina propria cells purified from the duodenum, jejunum, and ileum of PRCVand TGEV-inoculated pigs nor from TGEV-challenged pigs.
Weaned pigs: clinical signs, virus shedding, virus-neutralizing antibodies, and virusspecijic lymphocyte proliferative responses
Weaned pigs were studied to eliminate any possibility that passive lactogenic immunity from contact PRCV-exposed sows contributed to protection against TGEV. Prior to weaning, 1 l-day-old pigs that were inoculated with PRCV responded as did other primary PRCVexposed litters, i.e. all pigs shed virus in nasal secretions and seroconverted; none showed clinical signs of disease or shed virus in feces, After weaning (PID 10,3 weeks of age) and virulent TGEV challenge (PID 24) these primary PRCV-inoculated pigs and their agematched weaned controls were more resistant to disease than suckling pigs. None of the weaned pigs had diarrhea or shed virus in feces when the samples were tested by CCIF. Virus was detected by IEM of rectal swab supernatants from four pigs in each of the two weaned groups. When weaned and suckling pigs were compared, percentages of pigs with positive rectal virus shedding on PCD 2 and 3 as confirmed by IEM were: PRCV-inoculated pigs, 50% weaned vs. 83% suckling; and control TGEV-challenged pigs, 67% weaned vs. 78% suckling. All weaned pigs yielded negative postchallenge nasal swab samples except one control pig on PCD 1. Serum antibody titers in the weaned PRCV group increased about ten-fold following TGEV challenge compared with a lOO-fold increase in the suckling PRCV group. Weaned control pigs seroconverted with a typical primary virus-neutralizing serum antibody response.
Mononuclear cells from MLN, BLN, and spleens of weaned pigs exhibited trends in virus-specific lymphocyte proliferative responses that were similar to those observed in suckling pigs (Fig. 5 ). TGEV challenge of PRCV-inoculated pigs induced significant moderate ( > 47 000 cpm) MLN proliferation (P = 0.02) on PCD 4 that decreased to < 12 000 cpm and was significantly lower (P<O.O5) than MLN responses in TGEVreinoculated pigs and both weaned and suckling TGEV-challenged control pigs on PCD 12 ( Fig. 5 (A) ). Virus-specific lymphocyte proliferation was never detected in any of the small intestine lamina propria cells from PRCV-exposed and control weaned pigs.
Lymphocyte proliferative responses to mitogen of suckling and weaned pigs
When cellular immune function was assessed by PHA-induced proliferation of lymphocytes, responses in cells from MLN, BLN, and spleens averaged> 156, 000 cpm (Table  l) , PHA responses in cells from the small intestine lamina propria were markedly lower, Values for each sample were calculated as the mean counts per minute (cpm) of triplicate cultures with PHA minus the mean cpm of triplicate background control cultures. a Mononuclear cells from MLN, BLN. and spleens were incubated for 4 days with PHA before they were pulsed with tritiated thymidine. h Mononuclear cells were purified from the lamina propria of the duodenum, jejunum, and ileum and incubated for 3 days with PHA before they were pulsed with tritiated thymidine. ranging from < 11 000 cpm in the jejunum to about 62 000 cpm in the ileum, the latter value one-third that observed in MLN. These depressed lamina propria cell responses to PHA were directly attributable to a lower percentage of T cells present at this site and to the low numbers of viable cells present after 4 days in culture: less than 10% of the lamina propria cells vs. 50-60% of the MLN, BLN, and spleen cells survived. The 4 day incubation period of lamina propria cells with T cell mitogens was optimized for maximum PHA and Con A responses; Con A induced proliferation comparable to that of PHA-stimulated cultures (data not shown). The addition of feeder medium prepared from supernatants of Con A-stimulated porcine spleens and peripheral blood mononuclear cells to lamina propria cell cultures did not enhance cell viability. Within each of the six tissues, cells exhibited similar mitogenic reactivity regardless of virus exposure.
Discussion
Vigorous lymphocyte proliferative responses in MLN and BLN of TGEV-primed pigs indicate that virus-specific T cell responses correlated with complete protection after TGEV challenge of these pigs and that these T cells augment virus-specific B cell responses . Both suckling and weaned PRCV-primed pigs exhibited transient increases in virus-specific MLN proliferation at PCD 4 that were two-to three-fold greater than MLN responses in TGEV-challenged control pigs. PRCV exposure conferred partial protection against virulent TGEV in both suckling and weaned pigs based upon clinical signs, virus shedding in feces and nasal secretions, and virus-neutralizing serum antibody titers, The impact of virulent TGEV exposure on T cell subsets was most pronounced in GALT and MLN, lymphocytes in proximity to the primary TGEV replication site in villous enterocytes of the small intestine (lamina propria, i.e. GALT) or in the draining lymph nodes for GALT (MLN) .
These results showing that PRCV inoculation induced partial protection against virulent TGEV challenge concur with earlier reports on pigs exposed to European strains of PRCV at 5-6 weeks of age, then challenged 4 weeks later (Van Nieuwstadt et al., 1989; Cox et al., 1993) , and with one study on very young gnotobiotic pigs inoculated with the same PRCV strain (Wesley and Woods, 1992) . Less than half of our challenged suckling pigs developed diarrhea compared with 90% of the challenged control pigs. Positive virusspecific MLN proliferative responses at PCD 2 were coincident with the onset of primary TGEV-specific MLN proliferation in cells from control pigs; responses from PRCV-exposed suckling and weaned pigs peaked at PCD 4 and by PCD 12 were significantly lower than those in MLN from control and TGEV-reinoculated pigs (Fig. 5 ). Hence, PRCV exposure did not enhance the duration of TGEV-specific lymphocyte proliferation in MLN from challenged pigs, but the magnitude of the MLN response at PCD 4 was two-to three-fold greater than that observed in MLN from TGEV-challenged control pigs. Our investigation of TGEV-specific B cell responses from these same pigs disclosed that numbers of virusspecific IgA-and IgG-ASC in MLN were greatest at PCD 12 and did not differ significantly among the three groups of suckling pigs at this time point, although significant differences were observed at PCD 0, 2, and 4 . These data suggest that, despite the lack of persistent TGEV-specific lymphocyte proliferative responses in MLN of PRCVexposed pigs, T cell help afforded to B cells was sufficient to allow virus-specific IgA-and IgG-ASC responses in these pigs to eventually approach the ASC numbers in MLN of TGEV-reinoculated and TGEV-challenged control pigs. Virus-specific BLN cell proliferative responses were high before challenge of PRCV-exposed pigs, and their continuation after challenge correlated with complete protection against virus shedding in nasal secretions from all pigs in both suckling and weaned PRCV groups.
Cells from MLN, BLN, and spleens from 35-day-old TGEV-challenged control pigs, both suckling and weaned, gave proliferative responses consistent with the induction of primary immune responses (Fig. 5) . Positive TGEV-specific proliferation was noted in MLN and BLN of suckling control pigs at PCD 2, whereas significant responses in spleens were not measured until PCD 8. The decreased magnitude and delayed onset of virusspecific spleen cell proliferation in control pigs may reflect the fact that TGEV is not a systemic infection and is rarely isolated from the spleens of infected pigs (Furuuchi et al., 1978 (Furuuchi et al., / 1979 , and the relocation of antigen-specific T helper cells is mucosally restricted after gut immunization (Dunkley and Husband, 1987) . Age-dependent resistance to TGEV infections (Moon et al., 1973) was confirmed by milder clinical signs and less rectal virus shedding with lower titers after TGEV challenge of 35-day-old control pigs than was observed in 1 l-day-old pigs. However, nasal virus titers were greater than those measured in the younger pigs which may indicate resistance to TGEV infections in older pigs depends more on maturation of the gut than the respiratory mucosa.
A comparison of rectal virus shedding from suckling pigs detected by CCIF and IEM provides indirect evidence that intestinal virus-specific antibody might contribute to the partial protection observed in PRCV-inoculated pigs. Virus detection by CCIF may have been hampered by the decreased infectivity of antibody-coated virions, whereas positive IEM only requires the visualization of virus particles. Rectal swab samples from TGEVchallenged control pigs tested by both methods gave about the same percentage of positive pigs (71-78%), implying minimal interference by intestinal antibody. In contrast, the TGEV-reinoculated pigs that were probably secreting high levels of intestinal secretory IgA (Saif and Wesley, 1992) had one positive sample of five tested by IEM and none positive by CCIF. Only one PRCV-inoculated pig had virus detected by CCIF versus 83% of the pigs were positive by IEM. In our B cell study, we described low numbers of virus-specific IgA-ASC in the small intestine lamina propria after PRCV inoculation; however, in PRCVexposed pigs after TGEV challenge, we observed rapid, dramatic increases in virus-specific IgG-ASC in the gut lamina propria . Moreover, Cox et al. ( 1993) detected TGEV-specific IgA in feces of PRCV-inoculated pigs following TGEV challenge. The rapid induction of these secondary antibody responses might curtail TGEV replication and may also interfer with virus detection in assays such as CCIF. The second source of intestinal antibody is passive lactogenic immunity conferred to pigs suckling sows that were contact-exposed to TGEV or PRCV. Other reports have shown that PRCV exposure of sows stimulates the production of TGEV-neutralizing IgA in milk (Callebaut et al., 1990 ) and provides partial protection against TGEV challenge in suckling pigs (Bernard et al., 1989; Paton and Brown, 1990; De Diego et al., 1992) .
None of the 35day-old control or PRCV-exposed weaned pigs developed diarrhea after TGEV challenge, and both groups had less rectal virus shedding detected by IEM and CCIF when compared with suckling pigs. A more rapid replacement of villous enterocytes in the intestine may be one factor resulting in increased resistance to TGEV infection in older pigs (Moon et al., 1973; Saif and Wesley, 1992) . Maturation of the gut is accelerated in weaned pigs by a similar mechanism after they have recovered from the immediate postweaning damage to villous structure and function (Hall and Byrne, 1989) . Although weaned pigs sustained less enteric and respiratory TGEV infection after challenge based on reduced rectal and nasal virus shedding, virus-specific lymphocyte proliferative responses were comparable between weaned and suckling pigs within the control and PRCV-exposed groups.
FCM of mononuclear cells after virus exposure revealed increased percentages of CD2+, CD4+, and CD8 + T cells in all lymphoid tissues that were most pronounced in MLN and GALT from control pigs inoculated with virulent TGEV (Fig. 3) . The expansion of T cell subsets in MLN was coincident with the demonstration of virus-specific lymphocyte proliferation by cells of the same origin, although it is likely that TGEV-specific T cells were only a small part of the total T cell population. Our results are in accord with FCM data for other enteric and respiratory viruses describing increases in T cells (London et al., 1990; Kimpen et al., 1992) .
The observations of a predominance of CD4+ over CDS+ T cells in MLN and the lamina propria, and CD2+ T cell numbers about equal to those of sIg+ B cells in the duodenal lamina propria (Figs. 2, 3 and 4 ) corroborate previous reports on lymphocyte subset composition in approximately 40-day-old pigs (Rothkotter and Pabst, 1989; Rothkotter et al., 1991) . The excess of sIg+ B cells over CD2+ T cells in the ileal lamina propria is consistent with a description of ileal Peyer's patches in 6-week-old pigs (Rothkotter and Pabst, 1989) . We did not exclude Peyer's patches from the pieces of ileum subjected to collagenase treatment and would expect them to be part of the lamina propria cell preparation. Our data showing CD4+ T cells are more abundant than CD8+ cells in spleens of young pigs contrast with data from spleens of adult pigs where CD8' T cells outnumbered CD4+ cells (Saalmuller et al., 1989 (Saalmuller et al., , 1990 . The spleen was unique in that the presence of CD4+CD8+ spleen cells was suggested in 35 to 47-day-old pigs after TGEV challenge (Fig. 3) . Double positive T cells, uncommon in mice and humans, constitute a significant subset of peripheral blood lymphocytes from adult pigs (Pescovitz et al., 1985; Saalmuller et al., 1987) , but are less numerous in younger animals (Pescovitz et al., 1994) . The CD4 +CD8 + population has also been verified in spleens and MLN of adult pigs (Saalmuller et al., 1989 (Saalmuller et al., , 1990 .
Our FCM results demonstrating the sum of CD4+ and CD8+ cells was less than the percentage of CD2+ cells imply that a large proportion of the duodenal (746%) and ileal (3263%) lamina propria T cell population were CD2+CD4_CD8-cells (Fig. 3) . In contrast to humans and mice, blood from young pigs and ruminants contains a relatively high number of thymus-derived null T cells (CD2_CD4_CD88sIg-), many of which express the yS T cell receptor (TcR) (Hit-t et al., 1990; Hein and Mackay, 1991; Binns et al., 1992) . The y8 TcR+ cells are thought to provide non-MHC-restricted T cell immunity against infections of epithelial surfaces, including the gut mucosa. In swine, a subset of ~8 TcR+ cells has been identified as CD2+CD4_CDS-T cells that selectively accumulate in spleens and MLN, but are rarely found among circulating lymphocytes (Saalmuller et al., 1989 (Saalmuller et al., , 1990 . A high proportion of T cells from the jejunal and ileal lamina propria of land 5day-old, but not 12-and 40-day-old, pigs were the CD2+CD4_CD8-subset (Rothkotter et al., 1991) . However, our results suggest the presence of CD2+CD4_CD8-T cells in the lamina propria of both unexposed and TGEV-challenged pigs from 11 to 5 1 days of age. The mitogenic reactivity of porcine CD2+CD4_CD8-cells has not been described, but porcine null T cells are reported to be unresponsive to both PHA and Con A as well as to other antigenic stimuli (Binns, 1982) .
The functional activity of T cells from MLN, BLN, and spleens assessed by DNA synthesis in mitogen-stimulated cultures (Table 1) concurred with our previous work revealing no variation in mitogenic reactivity based upon the source of lymphocytes or virus exposure . The magnitude of lamina propria cell proliferation to mitogen, less than one-third of the response for cells from MLN, BLN, and spleens, agrees with an earlier report describing PHA and Con A responses of > 10 000 cpm in lamina propria cells of 3-week-old and adult pigs (Wilson et al., 1986) . Significant functional differences have been shown in the characteristics of circulating memory T cells compared with lamina propria cells. Circulating memory T cells give strong proliferative responses when restimulated by antigen in vitro (Sanders et al., 1988; Akbar et al., 1991) , circulating naive T cells proliferate preferentially to mitogens, and lamina propria memory T cells respond to antigenic restimulation by exhibiting effector functions (e.g. cytokine secretion and help for B cells) without marked proliferation (Zeitz et al., 1988) .
Our results are consistent with the hypothesis that lymphocytes from MLN, BLN, and spleens comprised both naive and memory T cell populations that demonstrated vigorous proliferative responses to both mitogen and TGEV antigen. Lymphocytes from the lamina propria probably included significant numbers of y6 TcR+ T cells and memory T cells that had encountered TGEV or PRCV after primary inoculation and migrated back to the lamina propria to exert their effector function; these cell populations may exhibit weak or no proliferative responses to antigenic restimulation (memory T cells) and depressed responses to T cell mitogens (~8 TcR+ T cells). Many questions regarding the composition and function of the porcine lamina propria remain to be answered. The magnitude of virusspecific lymphocyte proliferation in mucosa-associated lymphoid tissues (MLN and BLN) was directly attributable to TGEV or PRCV replication that occurred in the adjacent mucosa, whereas lymphocyte proliferation in a systemic lymphoid tissue (spleen) depended on the relocalization of virus or virus-sensitized lymphocytes from the mucosa. Limited intestinal replication of TGEV and enteric disease in PRCV-exposed pigs challenged with TGEV may result from any or all of the following mechanisms: ( 1) active B and T cell immunity confirmed by virus-specific IgG-and IgA-ASC in GALT and lymphocyte proliferative responses in MLN; (2) passive lactogenic immunity conferred on suckling pigs from contact-exposure of sows; (3) accelerated maturation of the gut with subsequent increased resistance to TGEV infection in weaned pigs. Substantial virus-specific lymphocyte proliferation in BLN or MLN before challenge correlated with complete protection from shedding TGEV after challenge in nasal secretions or feces, respectively. These results confirm that PRCV infection primes TGEV-specific cell-mediated immune responses and, thus, contributes to partial immunity against TGEV challenge.
